Eton Pharmaceuticals' GAAP loss for 3 months of 2022 was $5.33 million, compared to a profit of $5.116 million in the previous year. Revenue decreased 5.47 times to $2.176 million from $11.897 million a year earlier.
Warning BlackTerminal uses cookies in order to personalize and improve the usability of the service. If you do not want to use cookies, please change your browser settings. Accept